Profil
Valentin Fulga is the founder.
He founded Theravitae Co. Ltd. in 2003 and currently holds the title of Chief Executive Officer.
Dr. Fulga also held former positions at TheraVitae, Inc. as Chairman, President & Chief Executive Officer, at Hemostemix, Inc. as Director, and at W World Corp.
as Principal.
Dr. Fulga obtained an undergraduate degree from Ben-Gurion University of the Negev.
Aktiva positioner av Valentin Fulga
| Företag | Position | Start |
|---|---|---|
Theravitae Co. Ltd.
Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Offers stem cell therapies for cardiac patients | Verkställande Direktör | 2003-01-01 |
Tidigare kända positioner av Valentin Fulga
| Företag | Position | Slut |
|---|---|---|
| W WORL | Företagsledare/Principal | - |
| HEMOSTEMIX INC. | Direktör/Styrelseledamot | - |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology Develops and commercializes adult stem cell technologies | Verkställande Direktör | - |
Valentin Fulgas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
W World Corp.
W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products | Health Technology |
TheraVitae, Inc.
TheraVitae, Inc. BiotechnologyHealth Technology Develops and commercializes adult stem cell technologies | Health Technology |
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravitae Co. Ltd.
Theravitae Co. Ltd. Pharmaceuticals: MajorHealth Technology Offers stem cell therapies for cardiac patients | Health Technology |
Hemostemix, Inc.
Hemostemix, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes blood-derived stem cell therapies for medical conditions | Health Technology |
















